Literature DB >> 26387731

Theme 3: Non-invasive management of (recurrent) venous thromboembolism (VTE) and post thrombotic syndrome (PTS).

Arina J ten Cate-Hoek1, Jeffrey I Weitz2, David Gailani3, Karina Meijer4, Helen Philippou5, Annemieke C Bouman6, Y Whitney Cheung7, Thijs E van Mens7, Jose W Govers-Riemslag8, Minka Vries8, Suzanne Bleker7, Jossi S Biedermann9, S Carina M Stoof9, Harry R Buller7.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26387731      PMCID: PMC4784092          DOI: 10.1016/j.thromres.2015.07.036

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  59 in total

1.  Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Gordon H Guyatt; Elie A Akl; Mark Crowther; David D Gutterman; Holger J Schuünemann
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration.

Authors:  John Simes; Cecilia Becattini; Giancarlo Agnelli; John W Eikelboom; Adrienne C Kirby; Rebecca Mister; Paolo Prandoni; Timothy A Brighton
Journal:  Circulation       Date:  2014-08-25       Impact factor: 29.690

Review 3.  Recent insights into the role of the contact pathway in thrombo-inflammatory disorders.

Authors:  Maurits L van Montfoort; Joost C M Meijers
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2014-11-18

4.  Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: Opposite and synergistic effects of factors XI and XII.

Authors:  Carine J M Doggen; Frits R Rosendaal; Joost C M Meijers
Journal:  Blood       Date:  2006-08-24       Impact factor: 22.113

5.  The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients.

Authors:  P Prandoni; S Villalta; P Bagatella; L Rossi; A Marchiori; A Piccioli; E Bernardi; B Girolami; P Simioni; A Girolami
Journal:  Haematologica       Date:  1997 Jul-Aug       Impact factor: 9.941

Review 6.  Anti-inflammatory therapies for cardiovascular disease.

Authors:  Paul M Ridker; Thomas F Lüscher
Journal:  Eur Heart J       Date:  2014-05-26       Impact factor: 29.983

7.  Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial.

Authors:  Susan R Kahn; Stan Shapiro; Philip S Wells; Marc A Rodger; Michael J Kovacs; David R Anderson; Vicky Tagalakis; Adrielle H Houweling; Thierry Ducruet; Christina Holcroft; Mira Johri; Susan Solymoss; Marie-José Miron; Erik Yeo; Reginald Smith; Sam Schulman; Jeannine Kassis; Clive Kearon; Isabelle Chagnon; Turnly Wong; Christine Demers; Rajendar Hanmiah; Scott Kaatz; Rita Selby; Suman Rathbun; Sylvie Desmarais; Lucie Opatrny; Thomas L Ortel; Jeffrey S Ginsberg
Journal:  Lancet       Date:  2013-12-06       Impact factor: 79.321

8.  Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer.

Authors:  Giancarlo Agnelli; Daniel J George; Ajay K Kakkar; William Fisher; Michael R Lassen; Patrick Mismetti; Patrick Mouret; Umesh Chaudhari; Francesca Lawson; Alexander G G Turpie
Journal:  N Engl J Med       Date:  2012-02-16       Impact factor: 91.245

Review 9.  Anticoagulant effects of statins and their clinical implications.

Authors:  A Undas; K E Brummel-Ziedins; K G Mann
Journal:  Thromb Haemost       Date:  2013-11-28       Impact factor: 5.249

10.  Factor XI antisense oligonucleotide for prevention of venous thrombosis.

Authors:  Harry R Büller; Claudette Bethune; Sanjay Bhanot; David Gailani; Brett P Monia; Gary E Raskob; Annelise Segers; Peter Verhamme; Jeffrey I Weitz
Journal:  N Engl J Med       Date:  2014-12-07       Impact factor: 91.245

View more
  1 in total

Review 1.  Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network.

Authors:  Heinz Ludwig; Michel Delforge; Thierry Facon; Hermann Einsele; Francesca Gay; Philippe Moreau; Hervé Avet-Loiseau; Mario Boccadoro; Roman Hajek; Mohamad Mohty; Michele Cavo; Meletios A Dimopoulos; Jesús F San-Miguel; Evangelos Terpos; Sonja Zweegman; Laurent Garderet; María-Victoria Mateos; Gordon Cook; Xavier Leleu; Hartmut Goldschmidt; Graham Jackson; Martin Kaiser; Katja Weisel; Niels W C J van de Donk; Anders Waage; Meral Beksac; Ulf H Mellqvist; Monika Engelhardt; Jo Caers; Christoph Driessen; Joan Bladé; Pieter Sonneveld
Journal:  Leukemia       Date:  2018-05-02       Impact factor: 11.528

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.